{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:53:43Z","timestamp":1792760023418,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS076991-01"],"award-info":[{"award-number":["R01NS076991-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003010","name":"Ege \u00dcniversitesi","doi-asserted-by":"publisher","award":["2014\/TIP\/083"],"award-info":[{"award-number":["2014\/TIP\/083"]}],"id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ymthe.2019.08.017","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T10:59:15Z","timestamp":1567249155000},"page":"2123-2133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Afrooz","family":"Rashnonejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamhossein","family":"Amini Chermahini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cumhur","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Onay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00e7a","family":"Aykut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Baka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferda","family":"\u00d6zk\u0131nay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2019.08.017_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy \u2013 a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2019.08.017_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","year":"2008","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.ymthe.2019.08.017_bib3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","article-title":"Classification of spinal muscular atrophies","volume":"1","author":"Pearn","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2019.08.017_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JND-160177","article-title":"Type 0 spinal muscular atrophy: further delineation of prenatal and postnatal features in 16\u00a0patients","volume":"3","author":"Grotto","year":"2016","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2019.08.017_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/2231-0770.197512","article-title":"Very severe spinal muscular atrophy (type 0)","volume":"7","author":"Al Dakhoul","year":"2017","journal-title":"Avicenna J. Med."},{"key":"10.1016\/j.ymthe.2019.08.017_bib6","first-page":"15","article-title":"Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?","volume":"224","author":"Shababi","year":"2014","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.ymthe.2019.08.017_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4155\/tde.11.16","article-title":"Perinatal gene delivery to the CNS","volume":"2","author":"Rahim","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ymthe.2019.08.017_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.exphem.2008.02.007","article-title":"Early fetal gene delivery utilizes both central and peripheral mechanisms of tolerance induction","volume":"36","author":"Colletti","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib9","first-page":"107","article-title":"In utero gene therapy","volume":"2","author":"Larson","year":"2000","journal-title":"Ochsner J."},{"key":"10.1016\/j.ymthe.2019.08.017_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.017_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib12","doi-asserted-by":"crossref","first-page":"16060","DOI":"10.1038\/mtm.2016.60","article-title":"Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy","volume":"3","author":"Armbruster","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2019.08.017_bib13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.08.017_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ppul.24203","article-title":"Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy","volume":"54","author":"Al-Zaidy","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene abeparvovec: first global approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2019.08.017_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12033-015-9899-5","article-title":"Large-scale production of adeno-associated viral vector serotype-9 carrying the human survival motor neuron gene","volume":"58","author":"Rashnonejad","year":"2016","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41591-018-0106-7","article-title":"Fetal gene therapy for neurodegenerative disease of infants","volume":"24","author":"Massaro","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2019.08.017_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23305","article-title":"Correction of a pathogenic gene mutation in human embryos","volume":"548","author":"Ma","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.017_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2017.12.029","article-title":"High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors","volume":"273","author":"Ahmed","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2019.08.017_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.stem.2018.08.010","article-title":"Future AAVenues for in utero gene therapy","volume":"23","author":"MacKenzie","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2019.08.017_bib21","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1038\/s41467-018-04894-2","article-title":"In utero nanoparticle delivery for site-specific genome editing","volume":"9","author":"Ricciardi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.08.017_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/NEN.0b013e3181a10ea1","article-title":"The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation","volume":"68","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/424251b","article-title":"Looking into the safety of AAV vectors","volume":"424","author":"Kay","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.017_bib24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/mt.2011.280","article-title":"Self-complementary AAVs induce more potent transgene product-specific\u00a0immune responses compared to a single-stranded genome","volume":"20","author":"Wu","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib25","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1128\/JVI.74.20.9451-9463.2000","article-title":"Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in\u00a0vivo","volume":"74","author":"Nakai","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib26","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/JVI.03017-12","article-title":"Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release","volume":"87","author":"Horowitz","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbrc.2009.11.148","article-title":"Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy","volume":"391","author":"Butchbach","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2019.08.017_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/gt.2014.121","article-title":"Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats","volume":"22","author":"Hordeaux","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnana.2014.00042","article-title":"Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse","volume":"8","author":"Schuster","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ymthe.2019.08.017_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2011.11.121","article-title":"Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy","volume":"417","author":"Glascock","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2019.08.017_bib31","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1093\/hmg\/ddv332","article-title":"Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMN\u03947 mouse model of SMA","volume":"24","author":"Iyer","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.017_bib32","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s12035-015-9223-1","article-title":"A single injection of recombinant adeno-associated virus into the lumbar cistern delivers transgene expression throughout the whole spinal cord","volume":"53","author":"Guo","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib33","first-page":"227","article-title":"Cerebrospinal fluid transport: a lymphatic perspective","volume":"17","author":"Johnston","year":"2002","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.ymthe.2019.08.017_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gt.2012.6","article-title":"Intracellular transport of recombinant adeno-associated virus vectors","volume":"19","author":"Nonnenmacher","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1472-6750-8-49","article-title":"Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Liu","year":"2008","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib36","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1096\/fj.11-182311","article-title":"Intravenous administration of AAV2\/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system","volume":"25","author":"Rahim","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2019.08.017_bib37","doi-asserted-by":"crossref","first-page":"21505","DOI":"10.1038\/srep21505","article-title":"Age-related neurogenesis decline in the subventricular zone is associated with specific cell cycle regulation changes in activated neural stem cells","volume":"6","author":"Daynac","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.08.017_bib38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2019.08.017_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular\u00a0atrophy mice treated with trichostatin A plus nutrition","volume":"64","author":"Narver","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpeds.2009.01.071","article-title":"Vascular perfusion abnormalities in infants with spinal muscular atrophy","volume":"155","author":"Araujo","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ymthe.2019.08.017_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0022-510X(75)90034-9","article-title":"A comparison of the structure of small blood vessels in normal, denervated and dystrophic human muscle","volume":"26","author":"Musch","year":"1975","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ymthe.2019.08.017_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/08830738050200110301","article-title":"Finger cold-induced vasodilatation, sympathetic skin response, and R-R interval variation in patients with progressive spinal muscular atrophy","volume":"20","author":"Arai","year":"2005","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib44","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2019.08.017_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/hum.2006.113","article-title":"Preclinical characterization of a recombinant adeno-associated virus type\u00a01-pseudotyped vector demonstrates dose-dependent injection site inflammation\u00a0and dissemination of vector genomes to distant sites","volume":"18","author":"Flotte","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/hum.2012.052","article-title":"Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain","volume":"23","author":"Salegio","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib48","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1038\/mtna.2013.27","article-title":"Fetal brain-directed AAV gene therapy results in rapid, robust, and persistent transduction of mouse choroid plexus epithelia","volume":"2","author":"Haddad","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2019.08.017_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2019.08.017_bib50","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/mt.2011.107","article-title":"Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques","volume":"19","author":"Mattar","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.017_bib51","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nbt1117-998","article-title":"First AAV gene therapy poised for landmark approval","volume":"35","author":"Smalley","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2019.08.017_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gt.2015.92","article-title":"In\u00a0vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression","volume":"23","author":"Rashnonejad","year":"2016","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619304009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619304009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:45:34Z","timestamp":1778816734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001619304009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1525001619304009"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.017","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}